Enhancement of Apo2L/TRAIL-mediated cytotoxicity in esophageal cancer cells by cisplatin
Although expressing adequate levels of functional tumor necrosis factor–related apoptosis-inducing ligand (TRAIL) receptors DR4/DR5, significant proportion of cancer cells exhibit resistance to the cytotoxic effect of this ligand. Exposure of Apo2L/TRAIL-refractory cancer cells to cytotoxic chemothe...
Saved in:
Published in | Molecular cancer therapeutics Vol. 5; no. 12; pp. 2977 - 2990 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
American Association for Cancer Research
01.12.2006
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!